AI Article Synopsis

Article Abstract

Peripheral blood was collected from a clinically diagnosed 79-year old male sporadic Parkinson's disease patient. Peripheral blood mononuclear cells (PBMCs) were reprogrammed with the Yamanaka KMOS reprogramming factors using the Sendai-virus reprogramming system. The transgene-free iPSC line showed pluripotency verified by immunofluorescent staining for pluripotency markers, and the iPSC line was able to differentiate into the 3 germ layers in vivo. The iPSC line also showed normal karyotype. This in vitro cellular model can be used to study the mechanism of sporadic Parkinson's disease and to test new drugs. Resource Table.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2016.12.025DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
12
disease patient
8
patient peripheral
8
peripheral blood
8
sporadic parkinson's
8
derivation human
4
human induced
4
induced pluripotent
4
pluripotent stem
4
stem cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!